[go: up one dir, main page]

GB0408995D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0408995D0
GB0408995D0 GBGB0408995.9A GB0408995A GB0408995D0 GB 0408995 D0 GB0408995 D0 GB 0408995D0 GB 0408995 A GB0408995 A GB 0408995A GB 0408995 D0 GB0408995 D0 GB 0408995D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0408995.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0408995.9A priority Critical patent/GB0408995D0/en
Publication of GB0408995D0 publication Critical patent/GB0408995D0/en
Priority to PCT/EP2005/004270 priority patent/WO2005103045A1/en
Priority to EP05734941A priority patent/EP1740582A1/en
Priority to JP2007508842A priority patent/JP2007533693A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0408995.9A 2004-04-22 2004-04-22 Compounds Ceased GB0408995D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0408995.9A GB0408995D0 (en) 2004-04-22 2004-04-22 Compounds
PCT/EP2005/004270 WO2005103045A1 (en) 2004-04-22 2005-04-20 Acyl dihydro pyrrole derivatives as hcv inhibitors
EP05734941A EP1740582A1 (en) 2004-04-22 2005-04-20 Acyl dihydro pyrrole derivatives as hcv inhibitors
JP2007508842A JP2007533693A (en) 2004-04-22 2005-04-20 Acyl dihydropyrrole derivatives as HCV inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408995.9A GB0408995D0 (en) 2004-04-22 2004-04-22 Compounds

Publications (1)

Publication Number Publication Date
GB0408995D0 true GB0408995D0 (en) 2004-05-26

Family

ID=32344223

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0408995.9A Ceased GB0408995D0 (en) 2004-04-22 2004-04-22 Compounds

Country Status (4)

Country Link
EP (1) EP1740582A1 (en)
JP (1) JP2007533693A (en)
GB (1) GB0408995D0 (en)
WO (1) WO2005103045A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
CN101815533A (en) 2007-05-04 2010-08-25 弗特克斯药品有限公司 Be used for the treatment of the combined therapy that HCV infects
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
AR074882A1 (en) 2008-12-23 2011-02-16 Pharmasset Inc NUCLEOSID ANALOGS
WO2010075554A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthesis of purine nucleosides
TW201026715A (en) 2008-12-23 2010-07-16 Pharmasset Inc Nucleoside phosphoramidates
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (en) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 Nucleoside phosphoramidates
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
RS54368B1 (en) 2010-03-31 2016-04-28 Gilead Pharmasset Llc Crystalline (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1-(2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
TW201136945A (en) 2010-03-31 2011-11-01 Pharmasset Inc Purine nucleoside phosphoramidate
TW201242974A (en) 2010-11-30 2012-11-01 Gilead Pharmasset Llc Compounds
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
PL3650014T3 (en) 2013-08-27 2022-01-31 Gilead Pharmasset Llc Combination formulation of two antiviral compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009873A1 (en) * 2001-11-02 2005-01-13 Gianpaolo Bravi Acyl dihydro pyrrole derivatives as hcv inhibitors
TW200418848A (en) * 2002-10-24 2004-10-01 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
EP1740582A1 (en) 2007-01-10
WO2005103045A1 (en) 2005-11-03
JP2007533693A (en) 2007-11-22

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
GB0405937D0 (en) Compounds
GB0423673D0 (en) Compounds
GB0408995D0 (en) Compounds
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0408777D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0405279D0 (en) Compounds
GB0401657D0 (en) Compounds
GB0405936D0 (en) Compounds
GB0406915D0 (en) Compounds
GB0405899D0 (en) Compounds
GB0406918D0 (en) Compounds
GB0405774D0 (en) Compounds
GB0406963D0 (en) Compounds
GB0405198D0 (en) Compounds
GB0408774D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)